Reduced risk of myocardial infarction related to active commuting: Inflammatory and haemostatic effects are potential major mediating mechanisms

European Journal of Preventive Cardiology

Volumn 17, Issue 1, 2010, Pages 56-62

  Wennberg, Patrik ^a   Wensley, Frances ^b   Johansson, Lars ^a   Boman, Kurt ^a   di Angelantonio, Emanuele ^b   Rumley, Ann ^c   Lowe, Gordon ^c   Hallmans, Göran ^a   Jansson, Jan Hakan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

commuting; haemostasis; inflammation; myocardial infarction; physical activity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; AUTOMOBILES; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; EXERCISE; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SWEDEN; TRANSPORTATION;

EID: 77149123969     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32832f3b11     Document Type: Article

References (26)

1. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol 2005; 99: 1193–1204.
2. Wannamethee SG, Shaper AG. Physical activity and cardiovascular disease. Semin Vasc Med 2002; 2: 257–266.
3. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387–1397.
4. Lowe GD, Rumley A, Whincup PH, Danesh J. Hemostatic and rheological variables and risk of cardiovascular disease. Semin Vasc Med 2002; 2: 429–439.
5. Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286–1292.
6. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785–1790.
7. Wennberg P, Lindahl B, Hallmans G, Messner T, Weinehall L, Johansson L, et al. The effects of commuting activity and occupational and leisure time physical activity on risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006; 13: 924–930.
8. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007; 116: 2110–2118.
9. Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S. Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 1998; 16: 171–176.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583–612.
11. Rothman KJ. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
12. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241–2247.
13. Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project. Thromb Res 2005; 116: 223–232.
14. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5: e78.
15. Ditlevsen S, Christensen U, Lynch J, Damsgaard MT, Keiding N. The mediation proportion: a structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable. Epidemiology 2005; 16: 114–120.
16. Greenberg RS. Medical epidemiology. New York: Lange Medical Books/McGraw-Hill; 2005. pp. 206–207.
17. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868–874.
18. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.
19. Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 2000; 20: 271–279.
20. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFITnested case-control study. Multiple risk factor intervention trial. Am J Epidemiol 1996; 144: 537–547.
21. Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly study. Thromb Haemost 1998; 79: 129–133.
22. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 1563–1569.
23. Koenig W, Ernst E. Exercise and thrombosis. Coron Artery Dis 2000; 11: 123–127.
24. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000; 21: 21–24.
25. Thijssen DH, Rongen GA, Smits P, Hopman MT. Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations. J Physiol 2008; 586: 319–324.
26. Goldsmith RL, Bigger JT Jr, Steinman RC, Fleiss JL. Comparison of 24-h parasympathetic activity in endurance-trained and untrained young men. J Am Coll Cardiol 1992; 20: 552–558.